9. GlaxoSmithKline

Total Ad Spend: $170.6 million
Television: $70.3 million
Magazine: $84.8 million
Other: $15.5 million

GlaxoSmithKline ($GSK) is counting on respiratory drugs to help get it through rough times and spent nearly 60% of its total advertising budget on the inhaler product Advair Diskus alone. It also backed up its fish-oil cholesterol pill Lovaza as a rival from Amarin hit the market.

In the spotlight

Advair Diskus, $99 million
Lovaza, $22.8 million
Jalyn, $14 million



Suggested Articles

JAK drugs have run into safety issues, and if the label for AbbVie's Rinvoq is any indication, the FDA now believes those the issues are class-wide.

Rather than "we did the best we could," Vas Narasimhan, during an internal call with managers, said Novartis could have handled the Zolgensma crisis…

After five years of struggles, Sun Pharmaceutical has put the problems at its key plant in Halol, India behind it.